Variants of alpha-fetoprotein coding and expression sequences
AssigneeThe University of North Carolina at Chapel Hill
InventorsHiroshi Kubota, Lola M. Reid, Robert Storms
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of North Carolina at Chapel Hill
InventorsHiroshi Kubota, Lola M. Reid, Robert Storms
Estimating the term…
The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemopoietic cell line, K562, differ from the authentic AFP transcript, consisting of 15 exons, by lacking only exon 1. Instead of exon 1, vAFP transcripts use an additional one or two exons located in the 5′-untranslated region of the AFP gene. K562 expressed selectively vAFP, whereas a hepatocellular carcinoma cell line, HepG2, showed no detectable expression of vAFP. In normal adult tissues, vAFP transcripts is detected in the bone marrow, thymus and brain, but not the spleen, suggesting the expression occurs in normal hemopoietic progenitors. Moreover, CD34+Lin− hemopoietic stem/progenitor cells purified by flow cytometric sorting also express the variant transcripts.
A method of detecting a variant form of alpha-fetoprotein (AFP) mRNA comprising:
A method for detecting a polynucleotide of a variant form of alpha-fetoprotein (AFP), the method comprising:
Dependencies are inferred from the claim text.